T o achieve cellular iron deprivation by chelation, it is important to develop chelators with selective metal-binding properties. Selectivity for iron has long been the province of certain oxygen-donor chelators such as desferrioxamine, which target Fe(II1) and exploit the strength of a relatively ionic Fe ( 111) 
Introduction
We are studying the complexation chemistry of biometal ions, including Fe(II), Fe(III), Zn(I1) and Cu( I I), by novel tripodal hexadentate chelators. The seminal compound tachpyr [ N , N , N " -tris( 2-pyridylmethy1)-1,3,5 -&,cis-triaminocyclohexane] has been found to bind Fe(I1) to form [Fe(tachpyr) ]'+, which under aerobic conditions undergoes iron-mediated oxidative dehydrogenation of the aminomethylpyridyl arms, to afford Fe( 11)-imino complexes [Fe(tachpyr-ox-n)12+ (n = 2,4, 6) (Scheme 1). In all the complexes of Scheme 1 [ 11 the electron configuration of Fe( I I) is d6-low-spin, a state that is associated with high inertness and affinity of Fe(I1) binding [2] . By contrast, the N-methylated derivative of tachpyr, (N-Me),tachpyr (where Me is methyl), has an overall weaker interaction with Fe(I1) and no oxidative dehydrogenation activity, consistent with the observation that (Fe[(N-Me) ,tachpyr]) . (ClO,) , is a complex of high-spin Fe(I1) [l] .
Iron chelators, including desferrioxamine (DFO), pyridoxal isonicotinoyl hydrazones (PIHs) and tachpyr, are under consideration as antitumour agents [3, 4] . Cellular iron depletion by these chelators may play a role in their activity. Tachpyr is strongly cytotoxic towards cultured MBT2 (mouse bladder tumour) cells, IC,, % Because of the striking connections of the biological effects of tachpyr and derivatives to their metal-binding chemistry, we continue to elaborate their inorganic chemistry and chelator design aspects. Herein we describe the outcomes of several reactions designed to probe comparative interactions of tachpyr with iron and zinc ions, and the significance of these to selective chelation of iron into the + 2 state in vivo.
Biological chelation of Fe( I I) as an alternative to Fe(lll)
We pursue the thesis that the interaction of Fe(I1) with a suitable chelator may possess sufficient affinity and inertness to be of biological use. Because treatment of iron overload has been a major objective in chelator design, the development of iron chelators for medicinal use has largely focused on chelators with a preference for Fe( I I I), Some Fe( I I) complexes promote cellular oxidative damage, which argues against Fe(I1) chelation in iron-overload therapy. But redox activity that creates injurious radical species may be a desirable strategy in chemotherapy.
The tach framework is effective in metal chelation and allows adjustment of metal-binding properties by variation of pendant groups in tach derivatives
Tachpyr is built by addition of 2-pyridylmethyl groups to each N of tach (Scheme 2). T h e tach framework has two particular advantages: with a single cyclohexyl ring flip, it attains the metalbinding conformation (thus, a large entropy decrease is not needed to attain the needed conformation, which benefits stability and inertness; the property of predisposition) [7] , and secondly, + 2 biometals readily fit into the pocket created by the three tach nitrogens. Indeed, tachpyr readily complexes many metals, but the fit of Fe(II), Ni(II), Cu(II), Zn(I1) and Ga(II1) is better than larger metals such as Hg(I1) [1,8-101. 
Tachpyr prefers Fe(ll) to Zn(ll)
In order to investigate the selectivity of tachpyr for Fe(I1) relative to Zn(II), we conducted two displacement reactions in buffered pH 7.4 media under anaerobic conditions. The citrate3-ligand 
Adding steric hindrance to tachpyr decreases the preference for iron(l1)
We examined the binding preferences of the N-alkylated tachpyr derivative (N-Me),tachpyr (Scheme 1). We found that (N-Me),tachpyr readily bound Zn(I1) in p H 7.4 media, but Fe(I1) was not bound. It has been possible to prepare (Fe[(N-Me) ,tachpyr]) . (ClO,) , in methanol, probably because this medium lacks H,O+(aq) and OH-(aq) that compete with (N-Me),tachpyr for iron [l] . However, upon addition of this substance to pH 7.4 media, decomposition and precipitation occur. Further studies of metal exchange are in progress.
We obtained the X-ray structure of (Zn[(N- 
Zn(ll) is displaced from tachpyr by Fe(lll) and Fe(ll) under aerobic conditions
In a competition reaction under aerobic conditions, tachpyr was reacted with equal amounts of Fe(I1)-citrate and Zn(I1)-citrate (eqn 2), 
where DSS is sodium 2,2-dimethyl-2-silapentane-5-sulphonate [Me,Si(CH,),SO,Na]. [Zn(tachpyr)12+ was roughly quantitated by N M R spectroscopy, through integration of cyclohexyl Hs on the C-a to the amino groups ( 6 % 3.4 p.p.m.; Figure 2A ). Integrals were referenced to an internal standard, disuccinyl suberate at d(CH,-Si) % 0 p.p.m. Initially, [Zn(tachpyr)12+ formed in % 90"" (nominal error f 10"") conversion referenced to tachpyr concentration.
T h e amount of [Zn(tachpyr)]'+ decreased continuously over 2 days at 37 OC, to a % 56 f 10 O 0 remainder relative to the initial tachpyr concentration, accompanied by formation of a mixture of [Fe(tachpyr-ox-n)12+ (n = 2, 4) complexes. The presence of [Fe(tachpyr-ox-n) ]'+ was confirmed by the formation of NMR signals at 6 2.9-3.3.
Although these species could not be quantitated due to the complexity and breadth of the signals, their growth and approximate concentration relative to [Zn(tachpyr)12+ was monitored by HPLC. Using a Waters 600E/486/746 dual-pump system with UV detection at 254 nm, a Beckman Ultrasphere 4.6 x 25 cm RP-18 column was eluted with a gradient of 100 "'0 0.05 M triethylammonium We have previously observed that tachpyr is able to bind Fe(II1) from its Fe(II1)-ATP, complex [l] . T h e A T P complex is believed to be a constituent of the intracellular labile iron pool [ 13,141, and is presumably more weakly bound than Fe(II1)-citrate. Unfortunately, Fe(II1)-ATP, precipitates iron hydroxides under the conditions of a competition reaction, precluding its use as an Fe(II1) source in the present study.
Concl ud i ng remarks
T h e chemical properties of tachpyr are consistent with its action as a cellular iron-deprivation agent that complexes iron in vitro. T h e preference of tachpyr for iron over zinc indicates that tachpyr exploits the high stability and inertness typical of the d6-low-spin state of Fe( 11) . These preliminary studies demonstrate the need for measurement of stability constants and elucidation of reaction mechanisms in the interaction of tachpyr with biometal ions. Further modifications to tachpyr to adjust metal-binding and redox properties are also underway.
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